Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease
about
Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@ast
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@en
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@nl
type
label
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@ast
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@en
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@nl
prefLabel
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@ast
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@en
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@nl
P2860
P1476
Risk of Biologic Therapy-Assoc ...... rate-to-Severe Crohn's Disease
@en
P2093
Gary R Lichtenstein
Stephen B Hanauer
P2860
P407
P433
11 Suppl 8
P577
2012-11-01T00:00:00Z